Bakhu Holdings, Corp. Reports Earnings Results for the Third Quarter Ended April 30, 2021
June 21, 2021 at 11:40 pm IST
Share
Bakhu Holdings, Corp. announced earnings results for the third quarter ended April 30, 2021. For the third quarter, the company announced operating loss was USD 1.235 million compared to USD 606,835 a year ago. Net loss was USD 1.251 million compared to USD 613,010 a year ago. For the nine months, operating loss was USD 3.212 million compared to USD 709,580 a year ago. Net loss was USD 3.246 million compared to USD 721,223 a year ago.
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.
BAKHU HOLDINGS, CORP. 
